Kuo et al. [31] reported that miR-33a functions as a bone metastasis suppressor in lung cancer by targeting PTHrP. miR-33a is downregulated in lung cancer cells, which express high levels of PTHrP. Here, PTHLH is linked to lung carcinoma.